BioLargo, Inc. (BioLarge) develops and licenses technology, which focuses on odor & moisture control, disinfection and solutions for contaminated water. BioLarge’s BioLargo technology is CupriDyne, acts as a natural disinfectant. Additionally, the company has the right to market an iodine based water disinfection system known as Isan System. The Isan system, acquired from Ioteq IP Pty.Ltd., is an automated water disinfection system that reduces the incidence of fungal growth, spoilage, organisms and pathogens in water and on food. Its BioLargo technology and iodine based water disinfection system, the Isan system has commercial applications within the global industries, including agriculture, animal health, beach and soil environmental remediation, consumer products, food processing, medical, and water industries. The company’s strategy is focused on developing and providing novel products for human wound care field. In this direction, the company formed a subsidiary called BioLargo Medical Group, Inc. with focus on wound care market. The company is headquartered in La Mirada, California, the US. BioLargo, Inc. Key Recent Developments Dec 17, 2012: BioLargo On Track For FDA 510(k) Submission And Commercialization Of Advanced Wound Care Products Jun 17, 2013: BioLargo Establishes Water Subsidiary In US This comprehensive SWOT profile of BioLargo, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of BioLargo, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends). The profile contains critical company information including*, - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. For more information kindly visit : http://www.companyprofilesandconferences.com/researchindex/Materials-Chemicals-c25/BioLargo-Inc-BLGO-Financial-and-Strategic-SWOT-Analysis-Review1.html
Related Articles -
Materials market, Chemicals market.,
|